Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Deere & Company (DE) vs HCA Health Inc (HCA) Price & Performance

Deere & CompanyTrade
HCA Health IncTrade

Price performance (Past 24H)

Key statistics

Deere & Company vs HCA Health Inc — how do they compare? Deere & Company trades at $652.61 (market cap $175.95B), while HCA Health Inc trades at $443.75 (market cap $96.35B). The key difference: Deere & Company is the larger of the two by market cap, and Deere & Company pays the higher dividend (0.99%). Which is the better fit depends on your goals — on Pluang, investors hold Deere & Company for 75 Days and HCA Health Inc for 76 Days on average.

DEHCA
Market Cap
$175.95B$96.35B
Volume
1,387,2311,079,453
Sector
IndustrialsHealth
52-Week High
$709.48$545.13
52-Week Low
$439.11$361.32
Typical Hold Time
75 Days76 Days
Enterprise Value
$229.85B$146.88B
Dividend Yield
0.99%0.7%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Deere & Company

Deere & Company (DE) trades at $656.87, down 3.8% on the day, reflecting near-term pressure amid a broader bearish technical signal. The stock has demonstrated strong earnings momentum, beating estimates in the last three quarters, but faces headwinds from declining revenue and net income margins. Recent news highlights the company's focus on AI-driven agricultural solutions to counter cyclical downturns, while analyst consensus remains divided with a price target of $731.20 suggesting potential upside from current levels.

The outlook for DE is mixed; solid profitability metrics and consistent cash flow generation support the investment case, but cyclical exposure to agriculture equipment demand and elevated valuation ratios pose risks. Earnings growth and successful execution of technology initiatives are key catalysts for outperformance, though macroeconomic volatility could dampen near-term returns.

HCA Health Inc

HCA Healthcare (HCA) trades at $439.17, up 1.61% today, with a bullish technical signal and strong fundamental performance. Revenue grew to $75.6 billion in 2025, with net income reaching $6.78 billion, and the company has beaten EPS estimates for three consecutive quarters. Recent news includes an upcoming Q3 2026 earnings call and the completion of the College of Health Care Professions acquisition, highlighting operational expansion.

The outlook remains positive with a consensus price target of $461.12, though risks include ongoing legal investigations and high debt levels. Earnings growth and cost controls support upside potential, but investors should monitor regulatory developments and payer-mix pressures that could impact margins.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DE
100% Buy0% Sell
Avg holding period · 75 Days
HCA
100% Buy0% Sell
Avg holding period · 76 Days

Top news

Latest headlines on both assets

About Deere & Company

Deere is the world's leading manufacturer of agricultural equipment, producing some of the most recognizable machines in the heavy machinery industry. The company is divided into four reportable segments: production and precision agriculture, small agriculture and turf, construction and forestry, and John Deere Capital. Its products are available through an extensive dealer network, which includes over 1,900 dealer locations in North America and approximately 3,700 locations globally. John Deere Capital provides retail financing for machinery to its customers, in addition to wholesale financing for dealers, which increases the likelihood of Deere product sales.

Read more on DE →

About HCA Health Inc

HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.

Read more on HCA →